000			01409 a2200373 4500
005			20250513134822.0
264		0	_c19980407
008			199804s 0 0 eng d
022			_a0378-5955
024	7		_a10.1016/s0378-5955(97)00191-3 _2doi
040			_aNLM _beng _cNLM
100	1		_aSone, M
245	0	0	_aLoss of spiral ganglion cells as primary manifestation of aminoglycoside ototoxicity. _h[electronic resource]
260			_bHearing research _cJan 1998
300			_a217-23 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAnti-Bacterial Agents _xadverse effects
650	0	4	_aChild
650	0	4	_aCystic Fibrosis _xdrug therapy
650	0	4	_aGentamicins _xadverse effects
650	0	4	_aHair Cells, Auditory _xdrug effects
650	0	4	_aHearing Loss, High-Frequency _xchemically induced
650	0	4	_aHumans
650	0	4	_aNerve Degeneration _xchemically induced
650	0	4	_aSpiral Ganglion _xdrug effects
650	0	4	_aTemporal Bone _xdrug effects
650	0	4	_aTobramycin _xadverse effects
700	1		_aSchachern, P A
700	1		_aPaparella, M M
773	0		_tHearing research _gvol. 115 _gno. 1-2 _gp. 217-23
856	4	0	_uhttps://doi.org/10.1016/s0378-5955(97)00191-3 _zAvailable from publisher's website
999			_c9441693 _d9441693